AzTrials
AzTrials

CoughingMINOPPCNCT06982911

Comparison of Postoperative Pulmonary Complications Between Smokers and Nonsmokers

An observational study of Coughing and Post Operative Complications, run by mehmet özkılıç at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a prospective observational study designed to evaluate the effect of smoking on early postoperative respiratory symptoms such as cough, airway secretions, and wheezing in adult patients undergoing elective abdominal surgery. Participants will be divided into two groups based on smoking history. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Coughing, Post Operative Complications, Wheezing
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 May 2025to 29 Jul 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Adult patients between 18 and 60 years old scheduled for elective abdominal surgery at a tertiary care hospital. Participants include both current smokers and nonsmokers. All patients are American Society of Anesthesiologists (ASA) class I-II-III and free of known chronic respiratory diseases.

Who may be able to join

  • Age between 18 and 65 years
  • Undergoing elective abdominal surgery under general anesthesia
  • ASA physical status I-II-III
  • Able to provide informed consent
  • Classified as either active smoker (≥10 pack-years) or nonsmoker (never smoked or quit >1 year ago)

Who cannot join

  • Diagnosed chronic pulmonary disease (e.g., Obstructive Sleep Apnea, asthma, Chronic Obstructive Pulmonary Disease)
  • Acute respiratory tract infection within the past 30 days
  • Morbid obesity (Body Mass Index >35 kg/m²)
  • Emergency surgery
  • Pregnancy or breastfeeding
  • Refusal to participate

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gazi Yaşargil Training and Research Hospital

    Diyarbakır, 21070

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Postoperative Pulmonary Complications Between Smokers and Nonsmokers: A Prospective Cohort Study

This is a prospective observational study designed to evaluate the effect of smoking on early postoperative respiratory symptoms such as cough, airway secretions, and wheezing in adult patients undergoing elective abdominal surgery. Participants will be divided into two groups based on smoking history. The study aims to assess the incidence of minor pulmonary complications-such as increased secretions requiring suctioning, oxygen need, and early respiratory discomfort-within the first 24 hours after surgery. Data will be collected on parameters including secretion volume, oxygen saturation, aspiration frequency, and presence of cough or wheezing. The results will help determine whether active smoking is associated with a higher frequency of early postoperative pulmonary events.

Read the detailed description

Cigarette smoking is a well-established risk factor for adverse postoperative outcomes, including respiratory complications. However, many studies have primarily focused on major complications such as pneumonia, reintubation, or prolonged mechanical ventilation, often underestimating early and subtle pulmonary effects of smoking. This study aims to fill that gap by evaluating early minor postoperative pulmonary events-specifically cough, airway secretions, and wheezing-within the first 24 hours after extubation in adult patients undergoing elective abdominal surgery.

The study is designed as a prospective observational cohort conducted in a single tertiary-care hospital. Adult patients (aged 18-65) undergoing elective abdominal surgery under general anesthesia will be included. Participants will be classified into two groups based on smoking history: current smokers and non-smokers. The primary outcome is the occurrence of early minor pulmonary complications, including secretion burden requiring aspiration, Peripheral Oxygen Saturation(SpO₂ ) desaturation (SpO₂ <90%), presence of audible wheezing, and persistent postoperative cough. These events will be documented by trained clinical staff using standardized clinical criteria and data collection forms.

The hypothesis of this study is that active smokers are more likely to develop early minor pulmonary complications within the first 24 hours after surgery compared to non-smokers. The findings will contribute to a better understanding of early perioperative respiratory risk among smoking patients and may support the refinement of risk assessment and preoperative counseling.

Keywords
Smoking, Pulmonary Secretions, Postoperative Complication, Cough, Abdominal Surgery
Medical subject headings
Cough, Respiratory Sounds, Tobacco Smoking, Smoking, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06982911
Study groupRoleWhat they receive
Smoking GroupPatients with an active smoking history (defined as smoking ≥10 pack-years) undergoing elective abdominal surgery under general anesthesia. This group will be evaluated for early postoperative respiratory symptoms such as increased secretions, cough, and wheezing.
Nonsmoking GroupPatients with no active smoking history (never smoked or quit more than 1 year ago) undergoing elective abdominal surgery under general anesthesia. This group serves as the control and will be assessed using the same early postoperative respiratory criteria.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Early Postoperative Pulmonary Complications Within 24 Hours After Surgery

    The primary outcome is defined as the presence of at least one of the following respiratory findings within 24 hours after extubation: (1) increased airway secretions requiring aspiration, (2) persistent cough, (3) audible wheezing, or (4) oxygen desaturation below 90% on room air. These events will be documented by trained clinical staff using a standardized data collection form. Each patient will be assessed continuously for the first 6 hours and again at the 24th postoperative hour. The incidence of these pulmonary complications will be compared between smoking and nonsmoking patients.

    Measured: Within the first 24 hours after extubation

Secondary outcomes (3)
  1. Number of Suctions Required for Airway Secretion Clearance Within 6 Hours After Extubation

    This outcome measures the total number of suctioning procedures required to clear airway secretions during the first 6 hours after extubation. Suctioning is performed only when visible or audible secretions are present and is recorded by trained clinical staff using a standardized protocol.

    Measured: Within the first 1 hours after extubation

  2. Oxygen Desaturation Events Below 90% Within the First 24 Hours After Surgery

    This outcome tracks the number and duration of oxygen desaturation episodes defined as saturation(SpO₂) falling below 90% on room air within the first 24 hours after extubation. Each event is recorded by trained clinical personnel using pulse oximetry. Desaturation episodes that are corrected by airway maneuvers or supplemental oxygen are noted.

    Measured: Within the first 24 hours after extubation

  3. Association Between Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) Risk Score and Postoperative Pulmonary Complications

    The Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) score will be calculated preoperatively for all included patients using seven validated clinical parameters (age, preoperative saturation (SpO2), respiratory infection in the last month, preoperative anemia, surgical incision type, duration of surgery, and emergency status). This score will be evaluated as a secondary outcome to assess its correlation with the incidence of early postoperative pulmonary complications (PPCs). The score will also be included in multivariate analysis models and ROC curve analysis to determine predictive value and optimal cutoff thresholds.

    Measured: Within the first 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2025
  2. Study start1 May 2025
  3. Primary completion17 Jul 2025
  4. Study completion29 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06982911
Sponsor's protocol ID
GYEAH-PPC-001
Acronym
MINOPPC
Status last verified
Aug 2025
First submitted
13 May 2025
Last updated
3 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared because this is a single-center, observational study and no explicit consent for data sharing was obtained from participants. Only aggregate results will be published.

Questions about this trial

What is this clinical trial studying?

An observational study of Coughing and Post Operative Complications, run by mehmet özkılıç at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Early Postoperative Pulmonary Complications Within 24 Hours After Surgery (time frame: Within the first 24 hours after extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in